According to a study, US drug approvals from 2010 to 2019 correspond with the US disease burden but not the global burden.

Published Date: 13 Mar 2024

According to a study published in the, the number of expedited drug approvals could widen the gap between the 2010–2019 drug approvals in the US and the global burden of disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Global inequalities found in cancer research funding

2.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

3.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

4.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer

5.

Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot